Active Systemic Juvenile Idiopathic Arthritis
1 clinical trials · Condition
◉ Watch Active Systemic Juvenile Idiopathic Arthritis
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. (NCT05925452) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-12-01 |
Track Active Systemic Juvenile Idiopathic Arthritis automatically
Every clearance here is in the API, with alerts when new ones post.